Ciclosporin and the Cat Current Understanding and Review of Clinical Use

Introduction

Infiltration and destruction of the sebaceous glands by inflammatory cells (sebaceous adenitis) in cats, unlike dogs, is commonly associated with other histological elementary lesions such as interface dermatitis, landscape folliculitis or pan-epidermal keratinocyte apoptosis.^1,2 Clinical expression comprises severe exfoliation, scaling and crusting with variable levels of pruritus.^iii,four These clinical and histological signs accept, in some cases, been associated with thymoma,^iii,v,6 but not consistently. Because this histological syndrome shares some features with cutaneous lupus erythematosus or erythema multiforme, attempts to assign a specific name to the disease, in the absence of thymoma, have resulted in confusion, with authors describing similar cases as sebaceous adenitis,^7,8 lupus-like dermatitis,⁹ drug reaction² or 'non-thymoma-associated exfoliative dermatitis'.⁴ Although the pathogenesis of this disease (or these diseases) has not been elucidated, an immunopathological response to an undefined trigger is highly suspected.

Here, we study a instance of cat that adult generalised dermatosis characterised by alopecia, scaling, comedones and follicular casts, with histological signs of sebaceous adenitis, interface lymphocytic dermatitis and mural interface folliculitis, which fully responded to ciclosporin A. Control biopsies performed a few months after treatment initiation revealed resolution of the initial signs.

Instance clarification

A 6-year-one-time neutered female European Shorthair cat with free outdoor admission and only coincidental contact with other pets was referred for a ane-twelvemonth history of intermittent pruritus and fur loss. Prior to referral and because the true cat'south coat contained developed fleas, information technology had received a systemic ectoparasitic treatment (spinosad [Comfortis; Elanco]), which mildly improved the pruritus simply not the alopecia. The cat had likewise received brusque courses (unknown dosage) of subcutaneous amoxicillin/clavulanic acid (Duphamox; Zoetis) and oral prednisolone (Dermipred, Boehringer Ingelheim) without any improvement. The cat was otherwise good for you and was fed a high-quality dry out commercial feed.

Physical examination revealed no abnormalities other than dermatological signs. The true cat presented with generalised baldness with fur loss and broken hairs (Figure 1a). The entire skin was covered with pocket-sized whitish adherent scales (Figure 1b), which were especially numerous on the confront and muzzle. Follicular casts were observed on the caudal abdomen and extremities, and were associated with comedones on the ventral abdomen. The owners reported merely mild licking which, afterwards the dermatological examination, was not considered to be the sole crusade of the alopecia.

Figure 1

Initial physical examination: (a) generalised alopecia and scaling; and (b) close view of the dorsal peel showing abundant modest adherent whitish scales

The differential diagnoses included sebaceous adenitis, epitheliotropic T-prison cell lymphoma, dermatophytosis, demodicosis, exfoliative dermatitis associated or not with thymoma, drug reaction, feline immunodeficiency virus- or feline leukaemia virus-associated dermatosis, and Malassezia yeasts and/or bacterial overgrowth.

The consummate biochemistry console and claret count did not reveal any abnormalities, and the true cat tested negative for both retroviruses. Trichograms, skin scrapings and brushing production examination and fungal culture were negative. Skin cytology using coloured tape stripping did not reveal whatsoever signs of microorganism overgrowth and thoracic radiographs did not show any evidence of thymus neoplasia.

Multiple biopsies were obtained from the skin lesions nether general anaesthesia for histological examination. Samples were processed, cutting into 4 µm sections and stained with haematoxylin and eosin following standard procedures. Histological examination revealed a diffusely acanthotic epidermis with orthokeratotic hyperkeratosis. A rich, mainly lymphocytic, infiltrate at the dermo-epidermal junction, including the follicular wall (Effigy 2a), was observed. This infiltrate appeared to be more dumbo effectually the isthmus region of the pilus follicles and was associated with hydropic degeneration of the basal keratinocytes (Effigy 2b,c). No sebaceous glands were observed. Occasional apoptotic bodies were observed in the different epidermal layers. CD3 immunostaining revealed that the lymphocytes were mainly T-type cells (Figure 2d).

Figure 2

Histopathological test of biopsies taken from the flank. (a) Lymphocytic cell-rich interface dermatitis extending to the follicular wall (mural folliculitis) and lymphocytic exocytosis. No sebaceous glands, and simply an inflammatory infiltrate in the isthmal region (*), are observed. Annotation the diffuse irregular acanthosis (haematoxylin and eosin staining, magnification × 100, bar = 100 µm). (b,c) Hydropic degeneration of the basal cell layer of the epidermis with lymphocytic satellitosis (arrows) (haematoxylin and eosin staining, magnifications × 200 and × 400, confined = 100 µm and fifty µm). (d) Confirmation of the T-type cell nature of the cytotoxic lymphocytes (arrows) (CD3 immunostaining, ×400, bar = 50 µm)

The cat was treated with ciclosporin A (CsA) at a dosage of 6.75 mg/kg every 24 h (Atopica 25 mg, 1 sheathing per day; Elanco). A marked comeback was observed 3 weeks after first the treatment. The pruritus had ceased, the adherent scales had disappeared and fur regrowth was evident. CsA administration was reduced to 2/3 days at the same dosage (2 days on, ane twenty-four hours off). Five weeks later, the cat was still improving and presented a thick coat with no follicular casts or comedones. The only region that remained mildly alopecic was the dorsal attribute of the tail base of operations at the level of the supracaudal gland. CsA administration was reduced to once every 2 days and then to twice a calendar week, 1 month later (Effigy 3). Iv months after the initial consultation, the owner reported a very practiced general condition and normal skin aspect. However, shut dermatological exam revealed the presence of some follicular casts, comedones and scales on the dorsum. Administration was increased to once every 2 days, again with remission of the dermatological signs. 3 months later, the cat was anaesthetised for unrelated reasons, and skin biopsies were taken from a previously afflicted pare region. Histological examination showed resolution of the hyperkeratosis and only very mild focal perivascular lymphoplasmacytic dermatitis (Figure 4a). Sebaceous glands were nowadays and presented no signs of inflammatory infiltrate (Figure 4b). Haematology and biochemistry blood console were performed vi and 24 months after starting CsA treatment and were within normal limits.

Figure iii

Clinical presentation afterwards 3 months of treatment with ciclosporin A: (a) clinical resolution, hair regrowth; and (b) close view of the dorsal skin showing absence of scaling

Figure 4

Histological findings on follow-up skin biopsies afterward handling with ciclosporin A. (a,b) Disappearance of the interface inflammatory infiltrate and resolution of the epidermal acanthosis. Persistence of balmy diffuse orthokeratotic hyperkeratosis. Presence of normal-looking sebaceous glands without any associated signs of inflammation (asterisks and arrow). Haematoxylin and eosin staining, magnifications × forty and × 200, confined = 500 µm and 100 µm, respectively

Word

The clinical and histological pictures, taken together, were suggestive of an exfoliative dermatitis syndrome perhaps associated with a thymoma. Although no evidence of thymoma was apparent on the chest radiography, this imaging method cannot completely rule out the presence of small neoplastic foci. Intestinal ultrasonography was non performed, so the presence of other neoplasms associated with alopecic paraneoplastic diseases cannot be excluded.¹⁰ Still, the absenteeism of any general signs of illness despite the long grade of the illness (1 twelvemonth prior to referral and 24 months follow-up) and the extremely skilful response to immunomodulation make the paraneoplastic hypothesis less likely. As no underlying aetiology could be identified, the diagnosis could be suggestive of 'non-thymoma-associated exfoliative dermatitis syndrome'.

Like histological findings in two other cats were associated with cutaneous lupus erythematosus.^nine However, in addition to exfoliative dermatitis these animals had erosive–ulcerative lesions on the nose and trunk. Such lesions were non observed in the nowadays instance. However, a drug reaction could not be definitively ruled out in our case because the true cat periodically received external and internal antiparasitic treatments (spinosad, milbemycin oxime, praziquantel) and was correctly vaccinated once a twelvemonth. Nevertheless, this hypothesis seems unlikely considering clinical remission was achieved, even though these treatments were never stopped. Finally, a spontaneous resolution at the time of CsA handling initiation, as reported previously,¹¹ would seem highly unlikely in view of the long clinical course of the disease and the worsening and improvement of the condition following tapering and increasing the dosage of CsA.

The histological lesions with T-cell infiltration indicative of epidermal cytotoxicity (basal cell degeneration, apoptosis) would suggest an immune-mediated process and CsA, a calcineurin inhibitor, was considered as the drug of pick. CsA not only inhibits T-cell activation, but also affects several prison cell types in the skin, impairing the ability of dendritic cells to stimulate T-cell proliferation, decreasing the number and activity of Langerhans cells in the epidermis, decreasing cytokine secretion by keratinocytes, and decreasing the functions of mast cells and eosinophils.^12,13 In this case, clinical improvement was observed from first control iii weeks later on starting CsA treatment. This supports the idea of this illness beingness cell mediated and not driven past humoral immunity, which is less afflicted by CsA treatment and would accept longer to improve.¹⁴ CsA is used to treat idiopathic sebaceous adenitis in the domestic dog,^xv because information technology increases the number of sebaceous glands per pilus follicle and reduces perifollicular inflammation.^15,xvi A good response was obtained when CsA was used in cats with signs like to those described here.^iii,17 Based on our personal experience, nosotros elected to decrease the dose more slowly (from once daily to 2 days out of iii and then to every other mean solar day) than usually recommended.^fourteen Finally, to the best of our knowledge, the histological features of command biopsies from cats suffering from non-thymoma-associated exfoliative dermatitis treated with CsA have not been reported before.

Conclusions

CsA may be useful as a handling option for not-thymoma-associated exfoliative dermatitis assuasive resolution of both clinical and histological signs of the disease.

Author annotation This example report was presented in affiche format at the South European Veterinary Congress held in Seville (Kingdom of spain), 7–9 Nov 2019.

Acknowledgements

The authors are very grateful to the owners of the true cat for their standing collaboration. They thank Diana Warwick for English editing.

Conflict of involvement The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding The authors received no financial support for the research, authorship, and/or publication of this article.

Ethical approving This work involved the use of non-experimental animals but (owned or unowned), and followed established internationally recognised high standards ('best practice') of individual veterinary clinical patient care. Ethical approval from a committee was non necessarily required.

Informed consent Informed consent (either verbal or written) was obtained from the owner or legal custodian of all animal(south) described in this work for the procedure(southward) undertaken. For any animals or humans individually identifiable inside this publication, informed consent for their employ in the publication (verbal or written) was obtained from the people involved.

References

1 .

Miller WHJr, Griffin CE, Campbell KL . Parasitic pare affliction. In: Mosby E (ed.). Muller and Kirk'southward pocket-sized animal dermatology. 7th ed. St Louis, MO: Saunders, 2012, pp 284–342. Miller WHJr, Griffin CE, Campbell KL . Parasitic skin disease. In: Mosby E (ed.). Muller and Kirk's small animate being dermatology. 7th ed. St Louis, MO: Saunders, 2012, pp 284–342.

two .

Gross T, Ihrke P, Walder Due east , et al. Skin diseases of the domestic dog and true cat: clinical and histopathologic diagnosis. 2d ed. Oxford: Blackwell Scientific discipline, 2005, p 944. Gross T, Ihrke P, Walder E , et al. Skin diseases of the dog and cat: clinical and histopathologic diagnosis. second ed. Oxford: Blackwell Science, 2005, p 944.

3 .

Cavalcanti JV, Moura MP, Monteiro FO . Thymoma associated with exfoliative dermatitis in a true cat. J Feline Med Surg 2014; sixteen: 1020–1023.Google Scholar

4 .

Linek M, Rufenacht S, Brachelente C , et al. Nonthymoma-associated exfoliative dermatitis in 18 cats. Vet Dermatol 2015; 26: 40–45.Google Scholar

5 .

Forster-Van Hijfte MA, Curtis CF, White RN . Resolution of exfoliative dermatitis and Malassezia pachydermatis overgrowth in a cat later on surgical thymoma resection. J Small Anim Pract 1997; 38: 451–454.Google Scholar

6 .

Gojska-Zygner O, Karas-Tecza J, Lechowski R , et al. Cutaneous paraneoplastic syndrome in a cat with thymoma. Tierarztl Prax Ausg K Kleintiere Heimtiere 2013; 41: 255–259.Google Scholar

7 .

de Sepibus M, Buhler I, Hauser B , et al. Feline idiopathic mural folliculitis with sebaceous adenitis [in German language]. Schweiz Arch Tierheilkd 2004; 146: 89–91.Google Scholar

8 .

Glos Grand, von Bomhard W, Bettenay S , et al. Sebaceous adenitis and mural folliculitis in a true cat responsive to topical fatty acid supplementation. Vet Dermatol 2016; 27. DOI: 10.1111/vde.12282.Google Scholar

ix .

Wilhelm S, Grest P, Favrot C . 2 cases of feline exfoliative dermatitis and folliculitis with histological features of cutaneous lupus erythematosus. Tierarztliche Prax Ausg M Kleintiere Heimtiere 2005; 33: 364–369.Google Scholar

ten .

Pascal-Tenorio A, Olivry T, Gross TL , et al. Paraneoplastic alopecia associated with internal malignancies in the true cat. Vet Dermatol 1997; eight: 47–52.Google Scholar

11 .

Marignac G, Barlerin Fifty, Guillot J , et al. A example of seasonal lymphocytic mural folliculitis with spontaneous resolution in a cat [abstract]. Vet Dermatol 2003; 14: 247.Google Scholar

12 .

Al-Daraji WI, Grant KR, Ryan K , et al. Localization of calcineurin/NFAT in homo skin and psoriasis and inhibition of calcineurin/NFAT activation in human being keratinocytes by cyclosporin A. J Invest Dermatol 2002; 118: 779–788.Google Scholar

thirteen .

Palmeiro BS . Cyclosporine in veterinary dermatology. Vet Clin N Am Small Anim Pract 2013; 43: 153–171.Google Scholar

14 .

Colombo S, Sartori R . Ciclosporin and the cat: current agreement and review of clinical utilise. J Feline Med Surg 2018; twenty: 244–255.Google Scholar

15 .

Lortz J, Favrot C, Mecklenburg L , et al. A multicentre placebo-controlled clinical trial on the efficacy of oral ciclosporin A in the treatment of canine idiopathic sebaceous adenitis in comparison with conventional topical handling. Vet Dermatol 2010; 21: 593–601.Google Scholar

16 .

Linek Yard, Boss C, Haemmerling R , et al. Effects of cyclosporine A on clinical and histologic abnormalities in dogs with sebaceous adenitis. J Am Vet Med Assoc 2005; 226: 59–64.Google Scholar

17 .

Noli C, Toma Due south . Three cases of allowed-mediated adnexal skin disease treated with cyclosporin. Vet Dermatol 2006; 17: 85–92.Google Scholar

pattersondidettioners.blogspot.com

Source: https://bioone.org/journals/journal-of-feline-medicine-and-surgery-open-reports/volume-6/issue-1/2055116920902307/Clinical-and-histological-recovery-of-non-thymoma-associated-exfoliative-dermatitis/10.1177/2055116920902307.full

Share this post